Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Phase I/II trial to study the effectiveness of pyrazoloacridine plus carboplatin in treating
patients who have recurrent glioma. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die. Combining more than one drug may kill
more tumor cells.